This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

HLA matching is an important determinant of graft survival:

  • 1 year graft survival
    • if HLA identical then 95%
    • if one mismatch then 90-95%
    • if complete mismatch 75-80%

Cadaveric grafts have an average half-life of 8 years. This compares to a half-life of 20 years for HLA-identical graft from a living related donor.

Many deaths are from cardiovascular pathology which often is unrelated to transplantation or to immunosuppression.

Transplant related death is most commonly due to infection or malignancy.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.